EUVIMEDEUVIMED entdecken
Crossref

L26/P-156 Lysosomal Dysfunction Impairs Lactate-Mediated H3K18lac in Advanced Maternal Age Embryos

S. Guo, G. Huang, J. Li

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Guo und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How does metabolic dysfunction in embryos from advanced maternal age (AMA) affect development, and what are their etiologies and potential interventions? Summary answer Reduced lysosomal activity in AMA embryos impairs lactate dehydrogenase B (LDHB) degradation, which diminishes H3K18lac mediated by lactate and disrupts ZGA, compromising developmental potential. What is known already Advanced maternal age compromises embryonic developmental potential, with zygotic genome activation (ZGA) defects being one of the key factors. Epigenetic modifications critically regulate ZGA. Metabolites, such as lactate, can directly modulate this process via histone modifications, including H3K18lac. Aging also disrupts proteostasis, as lysosomal activity declines, leading to impaired degradation of metabolic enzymes. This suggests a link between lysosome-mediated protein degradation and metabolic-epigenetic dysregulation in ZGA. Study design, size, duration This study recruited 69 patients undergoing ART at our center in the past year. Immature germinal vesicle (GV) oocytes or discarded embryos (which were not clinically used for subsequent fertilization, culture, or transfer) were collected. Firstly, compared lactate levels during ZGA period between AMA and young embryos. Then, investigated the mechanism by which lysosomal dysfunction disrupts lactate metabolism in AMA embryos. Finally, a lysosomal activator was applied to rescue the impaired developmental potential. Participants/materials, setting, methods Human embryos came from the patients who donated embryos were between 20 and 30 years old and above 35 years old. ChIP-seq data was analyzed together with RNA-seq data. Female mice at 6-8 weeks and 11-12 months with C57BL/6J background were used. Performed gain- and loss-of-function experiments to validate the functional role of lactate metabolic regulation meditated by lysosomal in mice embryos. The lysosomal agonist EN6 was used to rescue the AMA embryos development. Main results and the role of chance This study investigates the underlying mechanism by which lactate metabolism regulates the developmental potential of AMA embryos according analyzed ZGA activity and histone lactylation modifications. (1) RNA-seq and immunofluorescence assays revealed that major ZGA is suppressed in aged embryos. Correspondingly, CUT&Tag analysis demonstrated a significant decrease in H3K18lac enrichment at major ZGA sites. The compromised developmental capacity of these embryos was partially rescued by supplementation with lactyl-CoA or NaLa. (2) Aged embryos exhibited elevated LDHB expression, and functional studies confirmed that LDHB regulates embryonic lactate content. (3) Aged embryos exhibit lysosomal dysfunction, leading to aberrant LDHB degradation. This interaction was further supported by IP‒MS analysis, indicating that LDHB is a target of lysosomal activity. Treatment with the lysosomal agonist EN6 restored lactate levels and H3K18 lactylation in aged mouse and human AMA embryos, thereby improving developmental efficiency. These results further demonstrate that lysosomal activity modulates AMA embryo development through lactate metabolism-mediated H3K18lac, a mechanism that appears conserved across species. Limitations, reasons for caution This study assessed developmental potential solely via blastocyst formation rate, lacking evaluation of implantation embryo developmental outcomes. Additionally, the range of lysosomal activators tested was limited, and their clinical applicability remains to be validated. Wider implications of the findings This study links lysosomal dysfunction to metabolism-mediated epigenetic dysregulation in aged embryos. It suggests that targeting lysosomal activity could be a novel strategy to improve the developmental potential of embryos from AMA patients. Trial registration number No

Zitieren

APA

Guo, S., Huang, G., & Li, J. (2026). L26/P-156 Lysosomal Dysfunction Impairs Lactate-Mediated H3K18lac in Advanced Maternal Age Embryos. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.492

Vancouver

Guo S, Huang G, Li J. L26/P-156 Lysosomal Dysfunction Impairs Lactate-Mediated H3K18lac in Advanced Maternal Age Embryos. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.492

BibTeX
@article{Guo2026,
  author = {Guo, S. and Huang, G. and Li, J.},
  title = {L26/P-156 Lysosomal Dysfunction Impairs Lactate-Mediated H3K18lac in Advanced Maternal Age Embryos},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.492}
}
Kostenlos starten →